MIM
PNT

Monashee Investment Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Monashee Investment Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,271
Closed -$658K – 445
2020
Q4 		$658K Hold
47,271
– – 0.09% 180
2020
Q3 		$680K Buy
+47,271
New +$645K 0.15% 105

Other funds holding PNT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Monashee Investment Management's PNT Position: Q1 2021 in Review

Monashee Investment Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q1 2021, closing a stake of 47,271 shares — an estimated $658K sold.

Monashee Investment Management first reported a position in PNT in Q3 2020 and held it in 2 quarters. The position peaked at $680K in Q3 2020. 28 funds tracked by Wall St. Rank hold PNT as of Q1 2021.

  • Monashee Investment Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Monashee Investment Management sold 47,271 POINT Biopharma Global Inc. Common Stock shares in Q1 2021, an estimated $658K.
  • Monashee Investment Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Monashee Investment Management's POINT Biopharma Global Inc. Common Stock position peaked at $680K in Q3 2020.
  • 28 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q1 2021.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.